A class of novel non-steroidal compounds are provided which are useful in treating diseases associated with modulation of the glucocorticoid receptor, AP-1, and/or NF-.kappa.B activity including obesity, diabetes, inflammatory and immune diseases, and have the structure of formula (I) ##STR00001## its stereoisomers thereof, or a solvate thereof, or a prodrug thereof, or a pharmaceutically acceptable salt thereof, where Z is CONR.sup.1R.sup.2 or CH.sup.2NR.sup.1R.sup.2 and where at least two of X.sub.1-X.sub.4 and/or X.sub.5-X.sub.8 is N or NR.sup.18, and R, R.sup.a, R.sup.b, R.sup.c, R.sup.d, R.sup.1, R.sup.2 and R.sup.18 are defined herein. Also provided are pharmaceutical compositions and methods of treating obesity, diabetes and inflammatory or immune associated diseases comprising said compounds.

Web www.patentalert.com

< Nucleic acids and corresponding proteins entitled 282P1G3 useful in treatment and detection of cancer

> Tricyclic compounds, compositions, and methods

> Growth arrest specific gene 6 peptides, antibodies, compositions, methods and uses

~ 00538